{
    "info": {
        "nct_id": "NCT03150914",
        "official_title": "Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial",
        "inclusion_criteria": "1. Female, age 18 or over\n2. Signed and dated informed consent\n3. Diagnosis of LAM as determined by compatible lung CT and one of the following\n\n   1. biopsy (lung, abdominal mass, lymph node or kidney) or cytology from thoracic or abdominal sources revealing LAM, or\n   2. tuberous sclerosis, angiomyolipomata (diagnosed by CT, MRI by the site radiologist or biopsy) or chylous pleural effusion (verified by tap), or\n   3. VEGF-D level ≥ 800 pg/ml.\n4. Post-bronchodilator forced expiratory volume in one second of > 70%\n5. Presence of markers of non-trivial burden of LAM or likely progression based on one of the following:\n\n   1. pretrial FEV 1 rate of decline of >60cc/yr, comparing enrollment FEV1 to any prior measurement in the past 3 years, or\n   2. baseline supplemental oxygen requirement with exercise, or\n   3. pre-menopausal and one of the following (if post-menopausal, must have a VEGF-D level ≥ 600 pg/ml and one of the following) baseline diffusing capacity for carbon monoxide ≤80% predicted,\n\na) baseline residual volume ≥120% predicted, b) baseline desaturation by 4% or more on six minute walk testing on room air c) more than 20 cysts on the carinal cut of the CT\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Existing or imminent (within 12-18 months) clinical indication for treatment with mTOR inhibitors, based on judgment of site investigator\n2. DLCO <60% predicted\n3. Resting room air saturation <90%\n4. Exercise induced desaturation nadir on room air < 85%\n5. History of myocardial infarction, angina or stroke related to atherosclerosis\n6. Pregnant, breast feeding, or plan to become pregnant in the next 2.5 years\n7. Inadequate contraception\n8. Significant hematologic, renal, metabolic or hepatic abnormality (i.e. transaminase levels > three times the UL of normal range, HCT < 30%, platelets < 80,000/mm3, adjusted absolute neutrophil count < 1,000/ mm3, total WBC < 3,000/ mm3), creatinine >2.5 mg/dl, uncontrolled hyperlipidemia\n9. Acute or chronic infection, such as (nontuberculous mucobacteria or active hepatitis B or C infections)\n10. Recent surgery (involving entry into a body cavity or requiring 3 or more sutures) within three weeks of initiation of study drug\n11. Use of sirolimus, everolimus or investigational treatment for LAM within the 30 days prior to randomization\n12. Previous lung transplantation or active on transplant list\n13. Inability to attend scheduled clinic visits, or perform pulmonary function testing\n14. Pleural effusion or chylous ascites sufficient to affect pulmonary function based on the opinion of the Site Investigator\n15. Acute pneumothorax within the past month\n16. History of malignancy in the past two years, other than squamous or basal cell skin cancer.\n17. Use of estrogen containing medications within the 30 days prior to randomization.\n18. Known allergy to sirolimus",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "2. baseline supplemental oxygen requirement with exercise, or",
            "criterions": [
                {
                    "exact_snippets": "baseline supplemental oxygen requirement with exercise",
                    "criterion": "supplemental oxygen requirement with exercise",
                    "requirements": [
                        {
                            "requirement_type": "baseline",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. VEGF-D level ≥ 800 pg/ml.",
            "criterions": [
                {
                    "exact_snippets": "VEGF-D level ≥ 800 pg/ml",
                    "criterion": "VEGF-D level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 800,
                                "unit": "pg/ml"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Female, age 18 or over",
            "criterions": [
                {
                    "exact_snippets": "Female",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "age 18 or over",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. biopsy (lung, abdominal mass, lymph node or kidney) or cytology from thoracic or abdominal sources revealing LAM, or",
            "criterions": [
                {
                    "exact_snippets": "biopsy (lung, abdominal mass, lymph node or kidney) ... revealing LAM",
                    "criterion": "biopsy from lung, abdominal mass, lymph node, or kidney",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "LAM"
                        }
                    ]
                },
                {
                    "exact_snippets": "cytology from thoracic or abdominal sources revealing LAM",
                    "criterion": "cytology from thoracic or abdominal sources",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "LAM"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Diagnosis of LAM as determined by compatible lung CT and one of the following",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of LAM",
                    "criterion": "lymphangioleiomyomatosis (LAM) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "compatible lung CT",
                    "criterion": "lung CT compatibility with LAM",
                    "requirements": [
                        {
                            "requirement_type": "compatibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "a) baseline residual volume ≥120% predicted, b) baseline desaturation by 4% or more on six minute walk testing on room air c) more than 20 cysts on the carinal cut of the CT",
            "criterions": [
                {
                    "exact_snippets": "baseline residual volume ≥120% predicted",
                    "criterion": "baseline residual volume",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 120,
                                "unit": "% predicted"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "baseline desaturation by 4% or more on six minute walk testing on room air",
                    "criterion": "desaturation on six minute walk testing on room air",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "%"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "more than 20 cysts on the carinal cut of the CT",
                    "criterion": "number of cysts on the carinal cut of the CT",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 20,
                                "unit": "cysts"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. pretrial FEV 1 rate of decline of >60cc/yr, comparing enrollment FEV1 to any prior measurement in the past 3 years, or",
            "criterions": [
                {
                    "exact_snippets": "pretrial FEV 1 rate of decline of >60cc/yr, comparing enrollment FEV1 to any prior measurement in the past 3 years",
                    "criterion": "FEV1 rate of decline",
                    "requirements": [
                        {
                            "requirement_type": "rate of decline",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "cc/yr"
                            }
                        },
                        {
                            "requirement_type": "comparison period",
                            "expected_value": "enrollment FEV1 to any prior measurement in the past 3 years"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Post-bronchodilator forced expiratory volume in one second of > 70%",
            "criterions": [
                {
                    "exact_snippets": "Post-bronchodilator forced expiratory volume in one second of > 70%",
                    "criterion": "post-bronchodilator forced expiratory volume in one second (FEV1)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 70,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Signed and dated informed consent",
            "criterions": [
                {
                    "exact_snippets": "Signed and dated informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dated",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. tuberous sclerosis, angiomyolipomata (diagnosed by CT, MRI by the site radiologist or biopsy) or chylous pleural effusion (verified by tap), or",
            "criterions": [
                {
                    "exact_snippets": "tuberous sclerosis",
                    "criterion": "tuberous sclerosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "angiomyolipomata (diagnosed by CT, MRI by the site radiologist or biopsy)",
                    "criterion": "angiomyolipomata",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": [
                                "CT",
                                "MRI",
                                "biopsy"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "chylous pleural effusion (verified by tap)",
                    "criterion": "chylous pleural effusion",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "verification_method",
                            "expected_value": "tap"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. pre-menopausal and one of the following (if post-menopausal, must have a VEGF-D level ≥ 600 pg/ml and one of the following) baseline diffusing capacity for carbon monoxide ≤80% predicted,",
            "criterions": [
                {
                    "exact_snippets": "pre-menopausal",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "pre-menopausal"
                        }
                    ]
                },
                {
                    "exact_snippets": "if post-menopausal, must have a VEGF-D level ≥ 600 pg/ml",
                    "criterion": "VEGF-D level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 600,
                                "unit": "pg/ml"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "baseline diffusing capacity for carbon monoxide ≤80% predicted",
                    "criterion": "baseline diffusing capacity for carbon monoxide",
                    "requirements": [
                        {
                            "requirement_type": "percentage of predicted",
                            "expected_value": {
                                "operator": "<=",
                                "value": 80,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Presence of markers of non-trivial burden of LAM or likely progression based on one of the following:",
            "criterions": [
                {
                    "exact_snippets": "Presence of markers of non-trivial burden of LAM",
                    "criterion": "markers of non-trivial burden of LAM",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "likely progression",
                    "criterion": "likely progression of LAM",
                    "requirements": [
                        {
                            "requirement_type": "likelihood",
                            "expected_value": "likely"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. DLCO <60% predicted",
            "criterions": [
                {
                    "exact_snippets": "DLCO <60% predicted",
                    "criterion": "DLCO",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 60,
                                "unit": "% predicted"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Inadequate contraception",
            "criterions": [
                {
                    "exact_snippets": "Inadequate contraception",
                    "criterion": "contraception",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Acute or chronic infection, such as (nontuberculous mucobacteria or active hepatitis B or C infections)",
            "criterions": [
                {
                    "exact_snippets": "Acute or chronic infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "acute",
                                "chronic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "nontuberculous mucobacteria",
                    "criterion": "nontuberculous mucobacteria infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "active hepatitis B or C infections",
                    "criterion": "hepatitis B or C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. Acute pneumothorax within the past month",
            "criterions": [
                {
                    "exact_snippets": "Acute pneumothorax within the past month",
                    "criterion": "acute pneumothorax",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. Pleural effusion or chylous ascites sufficient to affect pulmonary function based on the opinion of the Site Investigator",
            "criterions": [
                {
                    "exact_snippets": "Pleural effusion ... sufficient to affect pulmonary function based on the opinion of the Site Investigator",
                    "criterion": "pleural effusion",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "sufficient to affect pulmonary function based on the opinion of the Site Investigator"
                        }
                    ]
                },
                {
                    "exact_snippets": "chylous ascites sufficient to affect pulmonary function based on the opinion of the Site Investigator",
                    "criterion": "chylous ascites",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "sufficient to affect pulmonary function based on the opinion of the Site Investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Resting room air saturation <90%",
            "criterions": [
                {
                    "exact_snippets": "Resting room air saturation <90%",
                    "criterion": "resting room air saturation",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 90,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. Inability to attend scheduled clinic visits, or perform pulmonary function testing",
            "criterions": [
                {
                    "exact_snippets": "Inability to attend scheduled clinic visits",
                    "criterion": "attendance at scheduled clinic visits",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Inability to ... perform pulmonary function testing",
                    "criterion": "performance of pulmonary function testing",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "16. History of malignancy in the past two years, other than squamous or basal cell skin cancer.",
            "criterions": [
                {
                    "exact_snippets": "History of malignancy in the past two years",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "other than squamous or basal cell skin cancer",
                    "criterion": "malignancy type",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "squamous cell skin cancer",
                                "basal cell skin cancer"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Previous lung transplantation or active on transplant list",
            "criterions": [
                {
                    "exact_snippets": "Previous lung transplantation",
                    "criterion": "lung transplantation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active on transplant list",
                    "criterion": "transplant list status",
                    "requirements": [
                        {
                            "requirement_type": "active_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Recent surgery (involving entry into a body cavity or requiring 3 or more sutures) within three weeks of initiation of study drug",
            "criterions": [
                {
                    "exact_snippets": "Recent surgery (involving entry into a body cavity or requiring 3 or more sutures) within three weeks of initiation of study drug",
                    "criterion": "recent surgery",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "surgery_type",
                            "expected_value": [
                                "involving entry into a body cavity",
                                "requiring 3 or more sutures"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "17. Use of estrogen containing medications within the 30 days prior to randomization.",
            "criterions": [
                {
                    "exact_snippets": "Use of estrogen containing medications within the 30 days prior to randomization.",
                    "criterion": "estrogen containing medication use",
                    "requirements": [
                        {
                            "requirement_type": "use within time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Use of sirolimus, everolimus or investigational treatment for LAM within the 30 days prior to randomization",
            "criterions": [
                {
                    "exact_snippets": "Use of sirolimus, everolimus or investigational treatment for LAM within the 30 days prior to randomization",
                    "criterion": "use of sirolimus",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to randomization"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Use of sirolimus, everolimus or investigational treatment for LAM within the 30 days prior to randomization",
                    "criterion": "use of everolimus",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to randomization"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Use of sirolimus, everolimus or investigational treatment for LAM within the 30 days prior to randomization",
                    "criterion": "use of investigational treatment for LAM",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Significant hematologic, renal, metabolic or hepatic abnormality (i.e. transaminase levels > three times the UL of normal range, HCT < 30%, platelets < 80,000/mm3, adjusted absolute neutrophil count < 1,000/ mm3, total WBC < 3,000/ mm3), creatinine >2.5 mg/dl, uncontrolled hyperlipidemia",
            "criterions": [
                {
                    "exact_snippets": "transaminase levels > three times the UL of normal range",
                    "criterion": "transaminase levels",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "HCT < 30%",
                    "criterion": "hematocrit (HCT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "%"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "platelets < 80,000/mm3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 80000,
                                "unit": "per mm3"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "adjusted absolute neutrophil count < 1,000/ mm3",
                    "criterion": "adjusted absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1000,
                                "unit": "per mm3"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "total WBC < 3,000/ mm3",
                    "criterion": "total white blood cell count (WBC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3000,
                                "unit": "per mm3"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "creatinine >2.5 mg/dl",
                    "criterion": "creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2.5,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled hyperlipidemia",
                    "criterion": "hyperlipidemia",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. History of myocardial infarction, angina or stroke related to atherosclerosis",
            "criterions": [
                {
                    "exact_snippets": "History of myocardial infarction",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... angina",
                    "criterion": "angina",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... stroke related to atherosclerosis",
                    "criterion": "stroke related to atherosclerosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Existing or imminent (within 12-18 months) clinical indication for treatment with mTOR inhibitors, based on judgment of site investigator",
            "criterions": [
                {
                    "exact_snippets": "Existing or imminent (within 12-18 months) clinical indication for treatment with mTOR inhibitors",
                    "criterion": "clinical indication for treatment with mTOR inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 18,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "based on judgment of site investigator",
                    "criterion": "site investigator judgment",
                    "requirements": [
                        {
                            "requirement_type": "basis for indication",
                            "expected_value": "site investigator judgment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "18. Known allergy to sirolimus",
            "criterions": [
                {
                    "exact_snippets": "Known allergy to sirolimus",
                    "criterion": "allergy to sirolimus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Exercise induced desaturation nadir on room air < 85%",
            "criterions": [
                {
                    "exact_snippets": "Exercise induced desaturation nadir on room air < 85%",
                    "criterion": "exercise induced desaturation nadir on room air",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 85,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Pregnant, breast feeding, or plan to become pregnant in the next 2.5 years",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breast feeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "plan to become pregnant in the next 2.5 years",
                    "criterion": "pregnancy intention within next 2.5 years",
                    "requirements": [
                        {
                            "requirement_type": "intention",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}